1282 related articles for article (PubMed ID: 33379842)
1. [Analysis of pathogen spectrum and antimicrobial resistance of pathogens associated with hospital-acquired infections collected from 11 teaching hospitals in 2018].
Li SG; Liao K; Su DH; Zhuo C; Chu YZ; Hu ZD; Xu XL; Zhang R; Liu WE; Lu BH; Zeng J; Jin Y; Wang H
Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(47):3775-3783. PubMed ID: 33379842
[No Abstract] [Full Text] [Related]
2. [Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
Zhao C; Chen H; Wang H; Liu W; Zhuo C; Chu Y; Zeng J; Jin Y; Hu Z; Zhang R; Cao B; Liao K; Hu B; Xu X; Luo Y; Zou M; Su D; Wang Y; Tian B; Zhou H; Liu Y; Guo P; Zhou C; Chen X; Wang Z; Zhang F
Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(22):1739-46. PubMed ID: 26704158
[TBL] [Abstract][Full Text] [Related]
3. [An analysis of resistance of nosocomial infection pathogens isolated from 13 teaching hospitals in 2011].
Chen HB; Zhao CJ; Wang H; Cao B; Xu XL; Chu YZ; Hu ZD; Zhuo C; Hu BJ; Liu WE; Liao K; Zhang R; Zeng J; Wang Y; Luo YP; Wang ZW; Liu YM; Chen X; Tian B; Su DH; Zhou CM; Zou MX; Guo PH; Zhou HW; Jin Y
Zhonghua Nei Ke Za Zhi; 2013 Mar; 52(3):203-12. PubMed ID: 23856111
[TBL] [Abstract][Full Text] [Related]
4. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
Jia P; Zhu Y; Zhang H; Cheng B; Guo P; Xu Y; Yang Q
BMC Microbiol; 2022 Oct; 22(1):234. PubMed ID: 36182895
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study.
Tian L; Sun Z; Zhang Z
BMC Public Health; 2018 Sep; 18(1):1121. PubMed ID: 30219056
[TBL] [Abstract][Full Text] [Related]
7. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.
Zhang F; Li Y; Lv Y; Zheng B; Xue F
J Glob Antimicrob Resist; 2019 Jun; 17():276-282. PubMed ID: 30611932
[TBL] [Abstract][Full Text] [Related]
8. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
Mao T; Zhai H; Duan G; Yang H
Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
11. A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET).
Hu F; Yuan L; Yang Y; Xu Y; Huang Y; Hu Y; Ai X; Zhuo C; Su D; Shan B; Du Y; Yu Y; Lin J; Sun Z; Chen Z; Xu Y; Zhang X; Wang C; He L; Ni Y; Zhang Y; Lin D; Zhu D; Zhang Y
Front Cell Infect Microbiol; 2022; 12():1075185. PubMed ID: 36590586
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in Spain, 2004-2014.
Marco F; Dowzicky MJ
J Glob Antimicrob Resist; 2016 Sep; 6():50-56. PubMed ID: 27530839
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
Tian L; Zhang Z; Sun Z
Antimicrob Resist Infect Control; 2019; 8():86. PubMed ID: 31161033
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
Zhang Z; Chen M; Yu Y; Pan S; Liu Y
Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of tedizolid compared with other antibiotics against Gram-positive pathogens associated with hospital-acquired pneumonia, skin and soft tissue infection and bloodstream infection collected from 26 hospitals in China.
Li S; Guo Y; Zhao C; Chen H; Hu B; Chu Y; Zhang Z; Hu Y; Liu Z; Du Y; Gui Q; Ji P; Zeng J; Cao B; Fu Q; Zhang R; Wang Z; Zhuo C; Feng X; Jia W; Jin Y; Xu X; Liao K; Ni Y; Yu Y; Xu X; Hu Z; Lei JE; Yang Q; Wang H
J Med Microbiol; 2016 Oct; 65(10):1215-1224. PubMed ID: 27599998
[TBL] [Abstract][Full Text] [Related]
16. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
17. Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012).
Flamm RK; Farrell DJ; Sader HS; Jones RN
J Antimicrob Chemother; 2014 Jun; 69(6):1589-98. PubMed ID: 24562613
[TBL] [Abstract][Full Text] [Related]
18. Bloodstream Infections in the Intensive Care Unit: a Single-Center Retrospective Bacteriological Analysis Between 2007 and 2019.
Guzek A; Rybicki Z; Woźniak-Kosek A; Tomaszewski D
Pol J Microbiol; 2022 Jun; 71(2):263-277. PubMed ID: 35716169
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011-2016.
Dowzicky MJ; Chmelařová E
J Glob Antimicrob Resist; 2019 Jun; 17():44-52. PubMed ID: 30445209
[TBL] [Abstract][Full Text] [Related]
20. Genetic mechanisms and correlated risk factors of antimicrobial-resistant ESKAPEE pathogens isolated in a tertiary hospital in Malaysia.
Ngoi ST; Chong CW; Ponnampalavanar SSS; Tang SN; Idris N; Abdul Jabar K; Gregory MJ; Husain T; Teh CSJ
Antimicrob Resist Infect Control; 2021 Apr; 10(1):70. PubMed ID: 33892804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
